News

The award recognizes exceptional junior investigators for their notable research achievements, impactful findings and high potential for success as independent investigators.

At the 12th annual Helen and Robert Appel Alzheimer’s Disease Research Institute Symposium, scientists and clinicians shared their latest research which is advancing how Alzheimer’s disease is diagnosed and treated. 

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center are expanding the understanding of how the BCG treatment for early bladder cancer works.

Awards, honors and achievements for the month of May.

Dr. Juan R. Cubillos-Ruiz and Dr. David Lyden have been named inaugural recipients of the Pershing Square Foundation’s 2025 Ovarian Cancer Challenge Grant.

Four Weill Cornell Medicine investigators received the Ritu Banga Healthcare Disparities Research Awards, recognizing innovative research that will help close care gaps in clinical settings.

Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body’s immune system, for years sometimes.

On May 15, Weill Cornell Medicine honored Class of 2025 graduates from Weill Cornell Medical College and the Weill Cornell Graduate School.

Weill Cornell Medicine faculty members were honored with awards for their exemplary achievements in medical research, education and care May 14-15 during Weill Cornell Medicine’s commencement activities.

Medical and physician assistant students from the Class of 2025 were honored during convocation and certificate ceremonies May 14 for their dedication to scholarship, excellence in research, devotion to teaching or service and exceptional professional qualities.

Weill Cornell Graduate School of Medical Sciences celebrated students in the Class of 2025 for their academic achievements during its convocation ceremony on May 14.

Weill Cornell Medicine is fostering a new generation of researchers in Tanzania, with implications for improved health care outcomes worldwide.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian that compared the safety and efficacy of the injectable drugs. 

A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at Weill Cornell Medicine.

Using machine learning technology, a new study has identified three distinct profiles describing social and economic factors that are associated with a higher risk of suicide.

Weill Cornell Medicine has received a projected $4 million grant from the National Cancer Institute, part of the National Institutes of Health, to conduct a clinical trial testing whether a new imaging approach could reduce the need for biopsies to monitor prostate cancer.

Weill Cornell Medicine-Qatar awarded Cornell University medical degrees to 45 new doctors during the institution’s commencement ceremony May 7.

Dr. David C. Lyden received the prestigious Special Achievement Award from the International Society for Extracellular Vesicles 

Dr. Virginia Pascual, director of the Gale and Ira Drukier Institute for Children’s Health at Weill Cornell Medicine, has been elected to the American Academy of Arts and Sciences.